In addition, the DoD is hiring commercial aircraft to transport Nestlé formula from Switzerland to the United States
FRIDAY, May 20, 2022 (HealthDay News) — A bill that would allow families in a U.S. government assistance program to buy whatever brand of baby formula they can find is on the way to President Joe Biden to be signed into law.
The bill, which is meant to help families in the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) obtain baby formula in the midst of a nationwide shortage, was passed by the Senate on Thursday and by the House on Wednesday, the Associated Press reported.
Families in WIC receive vouchers that they redeem for specific foods, but the vouchers are typically limited to one brand of infant formula. The bill will allow them to buy any brand of formula that is available.
“Now, millions of parents will have an easier time finding the baby formula that they need,” said Senate Majority Leader Chuck Schumer, D-N.Y., the AP reported.
In related news, the U.S. Defense Department is hiring commercial aircraft to transport about 246 pallets of Nestlé formula from Switzerland to the United States, the Biden administration said Thursday. The products will include up to 1.5 million 8-ounce bottles of three hypoallergenic formulas for children with cow’s milk protein allergy: Alfamino Infant, Alfamino Junior, and Gerber Good Start Extensive HA, the AP reported. These formulas are a priority because they are medically important and in short supply, according to the White House.
2009 to 2023 Saw Surge in Probiotic Supplement Use
2021 to 2026 Saw Increase in State Funding for Suicide Prevention
Sugar-Sweetened Beverage, Fruit Juice Intake Linked to Hypertension Risk
Whole Goat Milk Formula Can Reduce Incidence of Atopic Dermatitis in Infants
Distinct Skin Microbiome Features Emerge Before Atopic Disease Onset in Infants
Risk for Herpes Zoster Elevated for Individuals With Atopic Dermatitis
Early Respiratory Infections Linked to Atopic Dermatitis Diagnosis
Review Shows Antihistamines Offer No Meaningful Benefit in Atopic Dermatitis